Bristol Gate Capital Partners Inc. lifted its holdings in shares of Stryker Corporation (NYSE:SYK) by 1.3% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 216,028 shares of the medical technology company’s stock after acquiring an additional 2,737 shares during the period. Stryker Corporation makes up approximately 4.7% of Bristol Gate Capital Partners Inc.’s investment portfolio, making the stock its 15th largest holding. Bristol Gate Capital Partners Inc. owned 0.06% of Stryker Corporation worth $30,680,000 as of its most recent SEC filing.
Other hedge funds have also modified their holdings of the company. Acrospire Investment Management LLC purchased a new stake in shares of Stryker Corporation during the second quarter worth about $111,000. Motco grew its stake in shares of Stryker Corporation by 50.7% during the second quarter. Motco now owns 826 shares of the medical technology company’s stock worth $115,000 after acquiring an additional 278 shares during the last quarter. Bollard Group LLC grew its stake in shares of Stryker Corporation by 0.4% during the second quarter. Bollard Group LLC now owns 832 shares of the medical technology company’s stock worth $115,000 after acquiring an additional 3 shares during the last quarter. Bruderman Asset Management LLC purchased a new stake in shares of Stryker Corporation during the second quarter worth about $150,000. Finally, James Investment Research Inc. purchased a new stake in shares of Stryker Corporation during the second quarter worth about $155,000. Institutional investors and hedge funds own 74.15% of the company’s stock.
In other news, insider Lonny J. Carpenter sold 5,000 shares of the company’s stock in a transaction that occurred on Friday, November 3rd. The stock was sold at an average price of $155.34, for a total transaction of $776,700.00. Following the completion of the transaction, the insider now directly owns 83,207 shares of the company’s stock, valued at approximately $12,925,375.38. The sale was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 7.40% of the company’s stock.
A number of brokerages have recently weighed in on SYK. ValuEngine upgraded Stryker Corporation from a “hold” rating to a “buy” rating in a research note on Tuesday. Royal Bank Of Canada reaffirmed a “buy” rating and set a $155.00 target price on shares of Stryker Corporation in a report on Monday, October 2nd. Oppenheimer Holdings, Inc. set a $156.00 target price on Stryker Corporation and gave the stock a “hold” rating in a report on Monday, October 30th. BidaskClub raised Stryker Corporation from a “hold” rating to a “buy” rating in a report on Thursday, August 17th. Finally, Cowen and Company set a $166.00 target price on Stryker Corporation and gave the stock a “buy” rating in a report on Sunday, October 29th. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and thirteen have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and an average target price of $151.52.
Shares of Stryker Corporation (NYSE SYK) traded up $1.27 during mid-day trading on Tuesday, hitting $155.75. The stock had a trading volume of 910,400 shares, compared to its average volume of 1,182,308. The company has a current ratio of 2.37, a quick ratio of 1.61 and a debt-to-equity ratio of 0.63. The firm has a market cap of $57,812.22, a P/E ratio of 24.48, a price-to-earnings-growth ratio of 2.43 and a beta of 0.79. Stryker Corporation has a twelve month low of $106.48 and a twelve month high of $160.62.
Stryker Corporation (NYSE:SYK) last announced its earnings results on Thursday, October 26th. The medical technology company reported $1.52 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.50 by $0.02. The business had revenue of $3.01 billion during the quarter, compared to the consensus estimate of $2.97 billion. Stryker Corporation had a return on equity of 24.11% and a net margin of 14.67%. The business’s quarterly revenue was up 6.1% on a year-over-year basis. During the same period in the prior year, the company posted $1.39 EPS. research analysts forecast that Stryker Corporation will post 6.47 EPS for the current year.
Stryker Corporation Profile
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).
Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.